EIF3G

Eukaryotic translation initiation factor 3 subunit G · O75821 · EIF3G on Sugi Atlas →

0 patent compounds predicted against EIF3G, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EIF3G by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer PHASE1/PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Quantification of GADD34 Expression in RA nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
miRNA as a Growth Plate Marker After GH nanUNKNOWN
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer nanRECRUITING
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a EIF3G binder may also engage these)

ProteinNameSimilarity
Q3ZC12 1.000 Q3ZC12 →
Q6DJI8 1.000 Q6DJI8 →
A7SKE9 1.000 A7SKE9 →
Q6DRC4 1.000 Q6DRC4 →
Q641B2 1.000 Q641B2 →
Q28CY2 1.000 Q28CY2 →
Q5RK09 0.999 Q5RK09 →
Q9Z1D1 0.999 Q9Z1D1 →
A8NS61 0.997 A8NS61 →
Q7QJV0 0.992 Q7QJV0 →
A3GGU2 0.992 A3GGU2 →
A5E1Z4 0.991 A5E1Z4 →
Q4P7G1 0.991 Q4P7G1 →
Q6CWX1 0.989 Q6CWX1 →
Q59ZV5 0.988 Q59ZV5 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.987 landscape →
Q6FRZ6 0.987 Q6FRZ6 →
Q6BT10 0.986 Q6BT10 →
P78795 0.986 P78795 →
Q19706 0.986 Q19706 →
Q1HE00 0.986 Q1HE00 →
Q759T4 0.986 Q759T4 →
Q5ZM16 0.985 Q5ZM16 →
Q8BHS3 0.985 Q8BHS3 →
P0CN53 0.984 P0CN53 →
O59800 0.983 O59800 →
A8WLV5 0.983 A8WLV5 →
Q6C747 0.983 Q6C747 →
P42698 0.983 P42698 →
Q54WM4 0.983 Q54WM4 →